Cite
HARVARD Citation
Nadler, E. et al. (n.d.). 3095 Subsequent line of therapy in metastatic NSCLC (mNSCLC): An indicator of success or failure?. European journal of cancer. pp. S631-S632. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nadler, E. et al. (n.d.). 3095 Subsequent line of therapy in metastatic NSCLC (mNSCLC): An indicator of success or failure?. European journal of cancer. pp. S631-S632. [Online].